The panoply of αβT cells in the skin

Journal of Dermatological Science

Volumn 76, Issue 1, 2014, Pages 3-9

  Nomura, Takashi ^a,b   Kabashima, Kenji ^b   Miyachi, Yoshiki ^b  

^a Ijinkai Takeda General Hospital   (Japan)

^b KYOTO UNIVERSITY   (Japan)

Author keywords

CD4T cells; CD8T cells; Innate like T cells; Memory T cells; Regulatory T cells; Skin T cells

Indexed keywords

ALPHA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 22; INTERLEUKIN 4; T LYMPHOCYTE RECEPTOR ALPHA CHAIN; T LYMPHOCYTE RECEPTOR BETA CHAIN; TRANSCRIPTION FACTOR FOXP3; TRANSFORMING GROWTH FACTOR BETA; CYTOKINE; FORKHEAD TRANSCRIPTION FACTOR; FOXP3 PROTEIN, HUMAN; INTERLEUKIN 17;

ACANTHOSIS; ALPHA BETA T LYMPHOCYTE; ATOPIC DERMATITIS; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL ACTIVATION; CELLULAR IMMUNITY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DRUG ERUPTION; ENVIRONMENTAL FACTOR; EPITHELIUM CELL; GRANULOCYTE; HELPER CELL; HUMAN; IMMUNE RESPONSE; IMMUNE SYSTEM; INFECTION; LICHEN PLANUS; LYMPHOCYTE FUNCTION; MEMORY T LYMPHOCYTE; MICROORGANISM; NATURAL KILLER T CELL; NONHUMAN; PERMEABILITY BARRIER; PROTECTION; PSORIASIS; REGULATORY T LYMPHOCYTE; REVIEW; SKIN; SKIN ALLERGY; SKIN DISEASE; SKIN FUNCTION; T LYMPHOCYTE; TH1 CELL; TH2 CELL; ANIMAL; CELL DIFFERENTIATION; CELL MEMBRANE; CYTOLOGY; HYPERSENSITIVITY; IMMUNOLOGY; KERATINOCYTE; METABOLISM; MOUSE; NATURAL KILLER CELL; PATHOLOGY; PHENOTYPE;

ANIMALS; CD8-POSITIVE T-LYMPHOCYTES; CELL DIFFERENTIATION; CELL MEMBRANE; CYTOKINES; DERMATITIS, ATOPIC; DRUG ERUPTIONS; FORKHEAD TRANSCRIPTION FACTORS; HUMANS; HYPERSENSITIVITY; INTERLEUKIN-10; INTERLEUKIN-17; KERATINOCYTES; KILLER CELLS, NATURAL; LICHEN PLANUS; MICE; PHENOTYPE; SKIN; T-LYMPHOCYTES; T-LYMPHOCYTES, HELPER-INDUCER; TH1 CELLS; TH2 CELLS; TRANSFORMING GROWTH FACTOR BETA;

EID: 84922335323     PISSN: 09231811     EISSN: 1873569X     Source Type: Journal    
DOI: 10.1016/j.jdermsci.2014.07.010     Document Type: Review

References (50)

1. Egawa G., Kabashima K. Skin as a peripheral lymphoid organ: revisiting the concept of skin-associated lymphoid tissues. J Invest Dermatol 2011, 131:2178-2185.
2. Clark R.A. Skin-resident T cells: the ups and downs of on site immunity. J Invest Dermatol 2010, 130:362-370.
3. Heath W.R., Carbone F.R. The skin-resident and migratory immune system in steady state and memory: innate lymphocytes, dendritic cells and T cells. Nat Immunol 2013, 14:978-985.
4. Mueller S.N., Gebhardt T., Carbone F.R., Heath W.R. Memory T cell subsets, migration patterns, and tissue residence. Annu Rev Immunol 2013, 31:137-161.
5. Clark R.A., Watanabe R., Teague J.E., Schlapbach C., Tawa M.C., Adams N., et al. Skin effector memory T cells do not recirculate and provide immune protection in alemtuzumab-treated CTCL patients. Sci Transl Med 2012, 4:117ra117.
6. Mora J.R., von Andrian U.H. T-cell homing specificity and plasticity: new concepts and future challenges. Trends Immunol 2006, 27:235-243.
7. O'Shea J.J., Paul W.E. Mechanisms underlying lineage commitment and plasticity of helper CD4+ T cells. Science 2010, 327:1098-1102.
8. Honda T., Egawa G., Grabbe S., Kabashima K. Update of immune events in the murine contact hypersensitivity model: toward the understanding of allergic contact dermatitis. J Invest Dermatol 2013, 133:303-315.
9. Lazarevic V., Glimcher L.H. T-bet in disease. Nat Immunol 2011, 12:597-606.
10. Kim B.S., Wojno E.D., Artis D. Innate lymphoid cells and allergic inflammation. Curr Opin Immunol 2013, 25:738-744.
11. Vercelli D. Immunoglobulin E and its regulators. Curr Opin Allergy Clin Immunol 2001, 1:61-65.
12. Kabashima K. New concept of the pathogenesis of atopic dermatitis: interplay among the barrier, allergy, and pruritus as a trinity. J Dermatol Sci 2013, 70:3-11.
13. Whitaker E.L., Filippov V.A., Duerksen-Hughes P.J. Interleukin 24: mechanisms and therapeutic potential of an anti-cancer gene. Cytokine Growth Factor Rev 2012, 23:323-331.
14. Kurebayashi Y., Nagai S., Ikejiri A., Koyasu S. Recent advances in understanding the molecular mechanisms of the development and function of Th17 cells. Genes Cells: Devoted Mol Cell Mech 2013, 18:247-265.
15. Yoshiki R., Kabashima K., Honda T., Nakamizo S., Sawada Y., Sugita K., et al. IL-23 from Langerhans cells is required for the development of imiquimod-induced psoriasis-like dermatitis by induction of IL-17A-producing gammadelta T cells. J Invest Dermatol. 2014, 134:1912-1921.
16. Martin D.A., Towne J.E., Kricorian G., Klekotka P., Gudjonsson J.E., Krueger J.G., et al. The emerging role of IL-17 in the pathogenesis of psoriasis: preclinical and clinical findings. J Invest Dermatol 2013, 133:17-26.
17. Toichi E., Torres G., McCormick T.S., Chang T., Mascelli M.A., Kauffman C.L., et al. An anti-IL-12p40 antibody down-regulates type 1 cytokines, chemokines, and IL-12/IL-23 in psoriasis. J Immunol 2006, 177:4917-4926.
18. Hueber W., Patel D.D., Dryja T., Wright A.M., Koroleva I., Bruin G., et al. Effects of AIN457, a fully human antibody to interleukin-17A, on psoriasis, rheumatoid arthritis, and uveitis. Sci Transl Med 2010, 2:52ra72.
19. Koga C., Kabashima K., Shiraishi N., Kobayashi M., Tokura Y. Possible pathogenic role of Th17 cells for atopic dermatitis. J Invest Dermatol 2008, 128:2625-2630.
20. Nakajima S., Kitoh A., Egawa G., Natsuaki Y., Nakamizo S., Moniaga C.S., et al. IL-17A as an inducer for Th2 immune responses in murine atopic dermatitis models. J Invest Dermatol 2014, 134:2122-2130. 10.1038/jid.2014.51.
21. Fujita H. The role of IL-22 and Th22 cells in human skin diseases. J Dermatol Sci 2013, 72:3-8.
22. Veldhoen M., Hirota K., Westendorf A.M., Buer J., Dumoutier L., Renauld J.C., et al. The aryl hydrocarbon receptor links TH17-cell-mediated autoimmunity to environmental toxins. Nature 2008, 453:106-109.
23. Brembilla N.C., Ramirez J.M., Chicheportiche R., Sorg O., Saurat J.H., Chizzolini C. In vivo dioxin favors interleukin-22 production by human CD4+ T cells in an aryl hydrocarbon receptor (AhR)-dependent manner. PLoS One 2011, 6:e18741.
24. Schmitt E., Klein M., Bopp T. Th9 cells, new players in adaptive immunity. Trends Immunol 2014, 35:61-68.
25. Schlapbach C., Gehad A., Yang C., Watanabe R., Guenova E., Teague J.E., et al. Human TH9 cells are skin-tropic and have autocrine and paracrine proinflammatory capacity. Sci Transl Med 2014, 6:219ra218.
26. Abbas A.K., Benoist C., Bluestone J.A., Campbell D.J., Ghosh S., Hori S., et al. Regulatory T cells: recommendations to simplify the nomenclature. Nat Immunol 2013, 14:307-308.
27. Josefowicz S.Z., Lu L.F., Rudensky A.Y. Regulatory T cells: mechanisms of differentiation and function. Annu Rev Immunol 2012, 30:531-564.
28. Hori S., Nomura T., Sakaguchi S. Control of regulatory T cell development by the transcription factor Foxp3. Science 2003, 299:1057-1061.
29. Ono M., Yaguchi H., Ohkura N., Kitabayashi I., Nagamura Y., Nomura T., et al. Foxp3 controls regulatory T-cell function by interacting with AML1/Runx1. Nature 2007, 446:685-689.
30. Kitoh A., Ono M., Naoe Y., Ohkura N., Yamaguchi T., Yaguchi H., et al. Indispensable role of the Runx1-Cbfbeta transcription complex for in vivo-suppressive function of FoxP3+ regulatory T cells. Immunity 2009, 31:609-620.
31. Halabi-Tawil M., Ruemmele F.M., Fraitag S., Rieux-Laucat F., Neven B., Brousse N., et al. Cutaneous manifestations of immune dysregulation, polyendocrinopathy, enteropathy, X-linked (IPEX) syndrome. Br J Dermatol 2009, 160:645-651.
32. Honda T., Miyachi Y., Kabashima K. Regulatory T cells in cutaneous immune responses. J Dermatol Sci 2011, 63:75-82.
33. Sanchez Rodriguez R., Pauli M.L., Neuhaus I.M., Yu S.S., Arron S.T., Harris H.W., et al. Memory regulatory T cells reside in human skin. J Clin Invest 2014, 124:1027-1036.
34. Sather B.D., Treuting P., Perdue N., Miazgowicz M., Fontenot J.D., Rudensky A.Y., et al. Altering the distribution of Foxp3(+) regulatory T cells results in tissue-specific inflammatory disease. J Exp Med 2007, 204:1335-1347.
35. Miyara M., Yoshioka Y., Kitoh A., Shima T., Wing K., Niwa A., et al. Functional delineation and differentiation dynamics of human CD4+ T cells expressing the FoxP3 transcription factor. Immunity 2009, 30:899-911.
36. Tomura M., Honda T., Tanizaki H., Otsuka A., Egawa G., Tokura Y., et al. Activated regulatory T cells are the major T cell type emigrating from the skin during a cutaneous immune response in mice. J Clin Invest 2010, 120:883-893.
37. Sakaguchi S., Yamaguchi T., Nomura T., Ono M. Regulatory T cells and immune tolerance. Cell 2008, 133:775-787.
38. Wing K., Onishi Y., Prieto-Martin P., Yamaguchi T., Miyara M., Fehervari Z., et al. CTLA-4 control over Foxp3+ regulatory T cell function. Science 2008, 322:271-275.
39. Ribas A. Tumor immunotherapy directed at PD-1. N Engl J Med 2012, 366:2517-2519.
40. Weiner H.L. The mucosal milieu creates tolerogenic dendritic cells and T(R)1 and T(H)3 regulatory cells. Nat Immunol 2001, 2:671-672.
41. Okamura T., Fujio K., Shibuya M., Sumitomo S., Shoda H., Sakaguchi S., et al. CD4+CD25-LAG3+ regulatory T cells controlled by the transcription factor Egr-2. Proc Natl Acad Sci U S A 2009, 106:13974-13979.
42. Gagliani N., Magnani C.F., Huber S., Gianolini M.E., Pala M., Licona-Limon P., et al. Coexpression of CD49b and LAG-3 identifies human and mouse T regulatory type 1 cells. Nat Med 2013, 19:739-746.
43. Mackay L.K., Rahimpour A., Ma J.Z., Collins N., Stock A.T., Hafon M.L., et al. The developmental pathway for CD103(+)CD8(+) tissue-resident memory T cells of skin. Nat Immunol 2013, 14:1294-1301.
44. Shiohara T. Fixed drug eruption: pathogenesis and diagnostic tests. Curr Opin Allergy Clin Immunol 2009, 9:316-321.
45. Godfrey D.I., Stankovic S., Baxter A.G. Raising the NKT cell family. Nat Immunol 2010, 11:197-206.
46. Shimizuhira C., Otsuka A., Honda T., Kitoh A., Egawa G., Nakajima S., et al. Natural killer T cells are essential for the development of contact hypersensitivity in BALB/c mice. J Invest Dermatol 2014.
47. Moodycliffe A.M., Nghiem D., Clydesdale G., Ullrich S.E. Immune suppression and skin cancer development: regulation by NKT cells. Nat Immunol 2000, 1:521-525.
48. Battaglia M., Stabilini A., Draghici E., Gregori S., Mocchetti C., Bonifacio E., et al. Rapamycin and interleukin-10 treatment induces T regulatory type 1 cells that mediate antigen-specific transplantation tolerance. Diabetes 2006, 55:40-49.
49. Nishimura H., Okazaki T., Tanaka Y., Nakatani K., Hara M., Matsumori A., et al. Autoimmune dilated cardiomyopathy in PD-1 receptor-deficient mice. Science 2001, 291:319-322.
50. Okazaki T., Honjo T. PD-1 and PD-1 ligands: from discovery to clinical application. Int Immunol 2007, 19:813-824.